A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Mammaglobin-A DNA Vaccine in Breast Cancer Patients With Metastatic Disease.
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2016
At a glance
- Drugs Breast cancer vaccine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 11 Jun 2013 Planned End Date changed from 1 Jan 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
- 11 Oct 2012 Planned End Date changed from 1 Dec 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov record.